Evidence check

Piperine’s Bioavailability Multiplier: What The Trials Measured

Black pepper extract is named last of six because its job is not to act on its own. It changes what happens to everything absorbed alongside it. That much is well established. What is less often said is that the size of the change is not one number: the published trials measured multipliers from roughly 30% to 2000%, depending entirely on what piperine was paired with.

By HoneyPower Team · Last updated September 25, 2026 · 10 min read · Evidence check

The claim behind the sixth ingredient

Black pepper extract, standardised versions of which are usually sold under trade names built around the word piperine, is included in supplement blends for one stated reason: it is supposed to increase how much of the other ingredients the body actually absorbs. That claim is not marketing invention. It has real trial support behind it. The part that gets lost in translation from research paper to sales copy is the size of the effect, which depends heavily on exactly what piperine is being combined with.

2000%: the number everyone quotes

the 1998 Shoba trial is the source of the figure that shows up across the entire bioavailability-enhancer industry. Curcumin, the pigment compound from turmeric, is notoriously poorly absorbed on its own because of rapid metabolism in the liver and intestinal wall. Shoba and colleagues gave 2 grams of curcumin alone to rats and to healthy human volunteers, then repeated the dose with 20 mg of piperine added.

Same combination, two species, a more than tenfold difference in the size of the effect between rats and humans — a reminder that even within one compound pairing, the multiplier is not a fixed constant.

In human subjects given curcumin alone, serum levels were either undetectable or very low. That is the real reason the multiplier looks so dramatic: curcumin’s baseline absorption is close to zero, so even a modest absolute increase in absorbed material produces an enormous percentage change. That is an important detail for reading the 2000% figure correctly — it is a real, replicated finding, and it is also a figure inflated by how poorly curcumin absorbs to begin with.

30%: the number almost nobody quotes

a 2000 double-blind trial ran the same basic design against a different compound: coenzyme Q10, a far better-absorbed molecule than curcumin to start with. Badmaev and colleagues gave healthy adult male volunteers 90 mg or 120 mg of coenzyme Q10, alone or combined with 5 mg of piperine, across single-dose, 14-day and 21-day protocols.

Supplementation with 120 mg of coenzyme Q10 plus piperine for 21 days produced a statistically significant, approximately 30% greater area-under-the-curve than coenzyme Q10 with placebo. That is a real, measured, statistically significant effect. It is also nowhere close to 2000%, because coenzyme Q10 does not start from the same near-zero baseline curcumin does.

What it does to two ordinary prescription drugs

a 1991 crossover study moved the question from supplements to actual prescription medicines. Bano and colleagues gave healthy volunteers a single dose of propranolol (40 mg) or theophylline (150 mg), alone or combined with 20 mg of piperine daily for seven days, and measured the pharmacokinetics of each drug.

Piperine produced an earlier time-to-peak, a higher peak concentration, and a higher total drug exposure (area under the curve) for propranolol. For theophylline, piperine produced a higher peak concentration, a longer elimination half-life, and a higher area under the curve. The authors themselves noted this could, in principle, be used clinically to improve the systemic availability of these drugs and reduce the dose needed — but the same mechanism cuts the other way for a medicine with a narrow safety margin, where a higher blood level is a risk rather than a benefit.

Why the effect happens at all

a 2002 mechanistic study identified the biology behind every result above. Bhardwaj and colleagues found piperine directly inhibits both P-glycoprotein, a transporter protein that pumps compounds back out of intestinal cells before they can be absorbed, and CYP3A4, an enzyme in the liver and gut wall that metabolises a very large share of orally taken drugs and compounds before they reach general circulation.

Inhibit the pump and the enzyme, and more of whatever was swallowed survives the trip through the gut wall and liver intact. That single mechanism explains why piperine raises blood levels of chemically unrelated compounds — curcumin, coenzyme Q10, propranolol, theophylline — using one shared biological gate rather than four separate mechanisms. It also explains why the size of the effect tracks how much of a given compound that gate was blocking in the first place, which is a property of the paired compound, not of piperine alone.

Piperine is already used this way, deliberately, in a real medicine

This is not a purely theoretical mechanism confined to research papers. a phase III clinical trial tested Risorine, a combination product pairing piperine with the tuberculosis antibiotic rifampicin, specifically because piperine improves rifampicin’s bioavailability enough to allow a lower rifampicin dose while maintaining efficacy, with the stated aim of reducing rifampicin-related side effects. That a piperine-containing combination product has gone through phase III testing as a deliberate bioavailability strategy is the strongest evidence available that the underlying effect is real and clinically usable, not a supplement-industry exaggeration.

What has never been measured

Here is the honest limit of all five studies above: every one of them tested piperine against a single, specific compound — curcumin, coenzyme Q10, propranolol, theophylline, rifampicin. None of them tested piperine against pure honey, Panax ginseng, maca root, Tribulus terrestris, or horny goat weed, the five ingredients piperine actually shares a capsule with on this label.

That gap matters because, as the curcumin-versus-coenzyme-Q10 comparison shows, the multiplier is specific to the compound being enhanced, not a general property that transfers automatically to whatever else is in the same capsule. Whether piperine meaningfully increases the absorption of any of this product’s other five named ingredients is, as far as the published literature goes, an open question rather than a demonstrated fact. It may well do something — the mechanism (P-glycoprotein and CYP3A4 inhibition) is broad enough that some effect on some of them is plausible — but “plausible” and “measured at 2000%” are different claims, and a label is not entitled to borrow the second to describe the first.

There is a fair objection to treating that gap as disqualifying, and it deserves a straight answer rather than a dismissal. Ginseng, maca, tribulus and horny goat weed are all, in different ways, poorly characterised on this label — no stated extraction ratio, no stated standardisation, in several cases no stated species or growing region, as this website’s other ingredient articles document at length. A compound that is poorly absorbed to begin with, the way curcumin was in the 1998 trial, is exactly the kind of compound where a piperine effect would be largest if one exists. So the honest position is not “piperine does nothing here.” It is “nobody has measured it, the mechanism suggests it plausibly does something, and the size of that something cannot be estimated from a curcumin trial or a coenzyme Q10 trial run on a different compound entirely.”

Four questions worth asking of any piperine row

1. Is a piperine percentage or milligram figure stated? Standardised extracts (commonly 95%+ piperine) are what the trials above actually tested; a raw “black pepper extract” weight is not the same claim.
2. Which compound is the enhancement claim being made about? A 2000% figure belongs to curcumin specifically, not to bioavailability enhancement in general.
3. Do you take a prescription medicine, especially one with a narrow safety margin? The propranolol and theophylline data show piperine can meaningfully raise drug blood levels.
4. Has this specific ingredient combination been tested? No published trial has measured piperine’s effect on any of this label’s other five named ingredients.

References